Peter G. Traber, President and CEO at GALECTIN THERAPEUTICS INC (GALT), bought 500 shares at $8.90 ($4K) on 2013-12-09, disclosed to the SEC on 2013-12-10.
Open-market purchase of $4k GALT by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| SELB | SELL | 2022-01-07 | $10K | — | Filing → |
| SELB | SELL | 2021-12-14 | $12K | — | Filing → |
| SELB | SELL | 2021-10-15 | $16K | — | Filing → |